We gebruiken cookies om ervoor te zorgen dat onze site zo soepel mogelijk draait. Als je doorgaat met het gebruiken van deze site, gaan we er vanuit dat je ermee instemt.
Waar kom je de pictogrammen tegen? Medicijngebruikers komen de pictogrammen straks tegen in de informatie die de apotheker geeft, bijvoorbeeld wanneer iemand een nieuw medicijn krijgt. Op termijn kom je ze ook tegen op verschillende webshops, op de webpagina’s waar men zelfzorgmedicijnen kunt kopen. Later verschijnen ze ook op het medicijndoosje zelf, op het schap […]
Er is te weinig bewijs om de transfusiepraktijk en het beleid te informeren over de impact van het geslacht van bloeddonoren bij transfusies. In de hu...
Statines zijn de bekende cholesterolverlagers. Patiënten hebben bij statinegebruik onder andere last van spierpijn waarna ze stoppen met de medicatie...
Resuscitation strategies for massive hemorrhage increasingly involve the use of low-titer group O whole blood (LTOWB) due to evidence suggesting impro...
Mixed agglutination is a serological pattern in some ambiguous ABO blood type identification. This study focused on the serological and molecular gene...
Measurement of transfused red blood cell (RBC) survival is relevant to the effective management of sickle cell disease (SCD). Following amustaline/glu...
Sanofi, through its philanthropic organization Foundation S, and Sobi, together with the World Federation of Haemophilia (WFH) and WFH USA, announce the signing of a contract providing support to the WFH
Dysfibrinogenemia is associated with thrombosis and bleeding. Identification is important as it correlates with adverse clinical outcomes. Clot wavefo...
Researchers at Children's Hospital of Philadelphia (CHOP) in collaboration with researchers at Royal Prince Alfred Hospital in Sydney, Australia announced the results of the longest follow─up study to date for individuals
To evaluate the impact of varying lipid turbidity (LT) levels on D-dimer measurements after routine centrifugation (RC) and high-speed centrifugation ...
Chimeric antigen receptor T cell (CAR-T) therapy has ushered in a new era in the management of patients with relapsed or refractory diffuse large B-cell lymphoma (LBCL), demonstrating unprecedented efficacy.(1) Despite these transformative outcomes, the clinical landscape of CAR-T therapy is not without challenges, and the occurrence of treatment-related toxicities remains a significant concern.
Chimeric antigen receptor T cell (CAR-T) therapy has ushered in a new era in the management of patients with relapsed or refractory diffuse large B-cell lymphoma (LBCL), demonstrating unprecedented efficacy.(1) Despite these transformative outcomes, the clinical landscape of CAR-T therapy is not without challenges, and the occurrence of treatment-related toxicities remains a significant concern.
ViroCell Biologics has manufactured a GMP-grade lentiviral vector for a University College London (UCL) clinical trial aimed at tackling relapse in pa...
Onderwerpen
Blogs
7 augustus 2023
Volg
